Recon: Medicago’s plant-based COVID vaccine secures first approval in Canada; BMS sues XSpray to block Sprycel generic
ReconJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy